The resurgence of therapeutic use of psychedelics undoubtedly marks the beginning of a new era. These substances, still mostly stigmatized and relegated to counter culture, are now at the heart of a profound transformation in the treatment of mental disorders affecting an exponentially growing number of patients.
In this unique book, an interdisciplinary team of Franco-Swiss scientists, including Christian Sueur, André Benezech, Bertrand Lebeau Lebovici, Federico Seràgnoli, and Romain Hacquet, experts in fields ranging from clinical psychology to addiction medicine, psychiatry, and pharmacology, come together to present a non-exhaustive synthesis of the use of molecules such as LSD, MDMA, DMT, or psilocybin in the treatment of conditions such as post-traumatic stress disorder (PTSD), depression, anxiety, or addiction.
From historical trips to cutting-edge research results, through powerful and unequivocal testimonies, this work offers a perspective that is both factual and current, rigorous and well-sourced, but above all focused on the well-being of the individual, addressing many questions and paving the way for an informed discussion on the proven role of psychedelics in therapeutic support.
With the exceptional participation of Rick Doblin, founder and president of MAPS, and under the scientific direction of Christian Sueur.